LabConnect and Bostwick Scientific Launch Centralized Anatomic Pathology Testing Service
Clinical and Anatomic Central Laboratory Services Combined
SEATTLE, WA-April 4, 2008-Central laboratory services provider LabConnect, announced today that it has signed Bostwick Scientific, the clinical trials division of Bostwick Laboratories, the world’s largest provider of centralized anatomic pathology testing services for clinical trials, as an exclusive provider.
The combination of Bostwick Scientific and LabConnect provide clinical trial sponsors with one source for key opinion leaders in anatomic pathology and central laboratory experts and combine the country’s fastest growing anatomic pathology lab and central lab. Bostwick Laboratories was formed in 1999 by David G. Bostwick, MD, MBA an internationally renowned expert in urologic pathology. Bostwick Laboratories operates six facilities in the U.S. and Europe and provides histological and cytological diagnosis in human pathology with special expertise in urogenital, gastrointestinal, gynecological, dermatologic and hematologic pathology. Bostwick Scientific has processed more than 35,000 clinical trial cases to date.
“We’re in the early stages of the evolution of anatomic pathology testing in clinical trials,” noted Eric Hayashi, LabConnect president and chief executive officer. “Sponsors are increasingly realizing the benefits of the centralization of their anatomic pathology testing needs just as they have realized similar benefits in centralizing routine and specialized clinical pathology.”
About LabConnect, LLC
LabConnect ( www.labconnectllc.com ), established in 2002, is a leading provider of central laboratory services to the biopharmaceutical industry. LabConnect’s global network of world-class laboratories provide an extensive menu of clinical trial testing services and have supported hundreds of clinical trials ranging from small single-site to large global studies with complex testing and logistical requirements.
About Bostwick Laboratories
Bostwick Laboratories ( www.bostwicklaboratories.com ) is a specialized anatomic pathology laboratory focused on the diagnosis of cancer. Bostwick Laboratories is a leader in urologic anatomic pathology, with expertise and a growing presence in the nephrology, gynecology, gastroenterology, and hematology sectors of the anatomic pathology market. Bostwick Laboratories is headquartered in Glen Allen, VA, and operates six laboratories located in VA, AZ, NY, FL, TN, and London, UK.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
